Agilent Technologies, Inc. vs Johnson & Johnson — Stock Comparison
Q·Score Breakdown
7.3
Bullish
Overall
7.1
Bullish
Quality
Health
Growth
Valuation
Sentiment
A
Consensus analyst target of $160.69 is 40% above current price.
⚠ earnings contracting 4% year-over-year.
JNJ
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
Analyst Consensus
BUY
Target $160.69 (+40.3%)
16 analysts
BUY
Target $252.42 (+11.1%)
24 analysts
Fundamentals
A
JNJ
25.3×
Trailing P/E
26.3×
17.4×
Forward P/E
17.9×
18.3%
Profit Margin
21.8%
52.3%
Gross Margin
68.0%
19.9%
ROE
26.4%
7.0%
Revenue Growth
9.9%
-3.6%
Earnings Growth
-52.9%
1.30
Beta
0.33
—
Price / Book
—
$32.4B
Market Cap
$546.9B
$104 – $160
52-Week Range
$146 – $252
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →